期刊文献+

化疗剂量强度对乳腺癌病人近期疗效的影响 被引量:1

The influence of dose intensity on the response of breast cancer chemotherapy
下载PDF
导出
摘要 目的:探讨化疗剂量强度对乳腺癌病人近期疗效的影响。方法:259例乳腺癌病人接受不同剂量强度的CMF方案进行术前化疗;评估其客观疗效。结果:(1)化疗对本组乳腺癌病人的总有效率是57%。(2)高剂量强度可以产生较好的化疗效果。结论:乳腺癌对化疗药物相对较敏感;提高药物剂量强度,可提高乳腺癌病人的近期疗效。 Objective: To evaluate the influence of dose intensity to the response of breast cancer chemotherapy. Method:Two hundred and fifty nine breast cancer patients had received preoperative CMF chemotherapy with different dose intensity and the objective responsive rates were evaluated. Results:Z(1) The overall response rate of this group of breast cancer patients was 57%. (2)The high dose intensity can lead to a better effect of chemotherapy. Conclusion: The breast cancer is relatively sensitive to the chemotherapy; higher dose intensity of chemotherapy could produce better shortterm therapeutic results for breast cancer patients.
作者 英子伟 张斌
出处 《癌症》 SCIE CAS CSCD 北大核心 1999年第3期307-308,共2页 Chinese Journal of Cancer
关键词 乳腺癌 药物疗法 药物剂量 疗效 Breast neoplasms Preoperative chemotherapy Dose intensity of chmotherapy Response rate of chemotherapy
  • 相关文献

参考文献2

  • 1张斌,中华肿瘤杂志,1997年,19卷,277页
  • 2潘启超,肿瘤药物学及化学治疗学,1989年,431页

同被引文献11

  • 1Kwak LW,Halpern J,Olshen RA,et al.Prognostic significance of actual dose intensity in diffuse large-cell lymphoma:Results of a tree-structured survival analysis[J].J Clin Oncol,1990,8(6):963~977
  • 2Itoh K,Ohtsu T,Wakita H,et al.Dose-escalation study of CHOP with or without prophylactic G-CSF in aggressive nonHodgkin's lymphoma[J].Ann Oncol,2000,11(10):1241~1247
  • 3JolyF.晚期卵巢癌患者高剂量与标准剂量顺铂治疗的比较[J].国外医学:妇产科学分册,2001,28(3):190-190.
  • 4Tobinai K,Hotta T.Clinical Trials for Malignant Lymphoma in Japan[J].JpnJ Clin Oncol,2004,34(7):369~378
  • 5Blayney DW,McGuire BW,Cruickshank SE.Increasing Chemotherapy Dose Density and Intensity:Phase Ⅰ Trials in Non-Small Cell Lung Cancer and Non-Hodgkin's Lymphoma[J].Oncologist,2005,10(2):138~149
  • 6Gregory SA,Case DC Jr,Bosserman L,et al.Fourteen-Day CHOP Supported with Granulocyte Colony-Stimulating Factor in Patients with Aggressive Non-Hodgkin's Lymphoma:Results of a Phase Ⅱ Study[J].Clin Lymph,2003,4(2):93~98
  • 7Wunderlich A,Kloess M,Reiser M,et al.Practicability and acute haematological toxicity of 2-and 3-weekly CHOP and CHOEP chemotherapy for aggressive non-Hodgkin's lymphoma:results from the NHL-B trial of the German High-Grade NonHodgkin's Lymphoma Study Group (DSHNHL)[J].Ann Oncol,2003,14(6):881~893
  • 8Pfreundschuh M,Trumper L,Kloess M,et al.Two-weekly or3-weekly CHOP chemotherapy with or without etoposide for the treatment of young patients with good-prognosis (normal LDH)aggressive lymphomas:results of the NHL-B1 trial of the DSHNHL[J].Blood,2004,104(3):626~633
  • 9Pfreundschuh M,Trumper L,Kloess M,et al.Two-weekly or 3-weekly CHOP chemotherapy with or without etoposide for the treatment of elderly patients with aggressive lymphomas:results of the NHL-B2 trial of the DSHNHL[J].Blood,2004,104(3):634~641
  • 10肖扬,高阳,李颂文,陈怀宇,宋朝阳,陈今友,梁华钦.造血干细胞/细胞因子支持下高剂量、多循环化疗治疗恶性淋巴瘤16例[J].实用医学杂志,2001,17(12):1166-1168. 被引量:5

引证文献1

二级引证文献3

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部